Tolerability and Safety of Transcranial Photobiomodulation for Mood and Anxiety Disorders
Cassano P, Norton R, Caldieraro MA, et al.
Photonics · 2022
- Study type
- Clinical safety analysis
- Population
- Adults with mood/anxiety disorders
- Source access
- Open access
Adult clinical safety and tolerability evidence for transcranial PBM in mood and anxiety disorders.
What to keep in mind
This paper concerns adults, not children. Tolerability observations apply to the studied devices, settings, participants and follow-up. They cannot establish safety for a developing brain, rule out rare or long-term harms, or justify unsupervised pediatric use.
Research information is not a prescription. Long-term pediatric transcranial PBM safety is not established by these studies; adult evidence is not a substitute for pediatric evidence. Use only under qualified clinical guidance, with device-specific safety review.
Read the open-access articleThe original publication opens at its journal or research repository. Full text availability depends on the source; articles have not been copied or rehosted.